These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22467990)

  • 21. Cardiovascular variability as a function of sleep-wake behaviour in narcolepsy with cataplexy.
    Silvani A; Grimaldi D; Barletta G; Bastianini S; Vandi S; Pierangeli G; Plazzi G; Cortelli P
    J Sleep Res; 2013 Apr; 22(2):178-84. PubMed ID: 23217021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
    Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
    Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
    Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
    Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sympathetic and cardiovascular activity during cataplexy in narcolepsy.
    Donadio V; Plazzi G; Vandi S; Franceschini C; Karlsson T; Montagna P; Vetrugno R; Bugiardini E; Mignot E; Liguori R
    J Sleep Res; 2008 Dec; 17(4):458-63. PubMed ID: 19021855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypocretin/orexin and narcolepsy: new basic and clinical insights.
    Nishino S; Okuro M; Kotorii N; Anegawa E; Ishimaru Y; Matsumura M; Kanbayashi T
    Acta Physiol (Oxf); 2010 Mar; 198(3):209-22. PubMed ID: 19555382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
    Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
    Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice.
    Thankachan S; Kaur S; Shiromani PJ
    J Neurosci; 2009 Feb; 29(5):1580-5. PubMed ID: 19193905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
    Vankova J; Stepanova I; Jech R; Elleder M; Ling L; Mignot E; Nishino S; Nevsimalova S
    Sleep; 2003 Jun; 26(4):427-30. PubMed ID: 12841368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
    Martínez-Rodríguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J
    Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
    Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal changes in blood pressure and heart rate in children with narcolepsy with cataplexy.
    Wang J; Yan Z; Dong X; Li J; Zhao L; Zhang X; Lv C; Zhao Z; Strohl KP; Han F
    J Sleep Res; 2023 Apr; 32(2):e13736. PubMed ID: 36163423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice.
    Bastianini S; Silvani A; Berteotti C; Lo Martire V; Zoccoli G
    J Sleep Res; 2012 Apr; 21(2):185-8. PubMed ID: 21883592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
    Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
    J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.
    John J; Wu MF; Siegel JM
    Sleep Res Online; 2000; 3(1):23-8. PubMed ID: 11382896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
    Heier MS; Jansson TS; Gautvik KM
    J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory regulation in narcolepsy.
    Han F
    Sleep Breath; 2012 Mar; 16(1):241-5. PubMed ID: 21318258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.